Current Studies

The Division of Urologic Surgery

• Culley Carson, MD
  • A phase IIb, multi-center, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PSD502 in subjects with Premature Ejaculation (PE).
•  Richard Sutherland, MD

  • 12-week, multicenter, double-blind, randomized, placebo-controlled, parallel-

    group study to investigate the efficacy, pharmacodynamic and safety of two doses of alfuzosin (0.1 mg/kg/day; 0.2 mg/kg/day) in the treatment of children and adolescents 2-16 years of  age with elevated detrusor leak point pressure of neuropathic etiology followed by a 40-week open-label extension